Clinical Trial

Mind-Body Interventions in Coronary Artery Disease

Study acronym: MBI-CAD
Recruiting
View on ClinicalTrials.gov →
Summary
This randomized controlled study aims to evaluate the effects of a combined mind-body intervention consisting of progressive muscle relaxation and guided imagery on psychological outcomes in patients with stable coronary artery disease. A total of 40 participants will be randomly assigned to either an intervention group or a control group. The intervention group will receive eight individualized sessions over four weeks in addition to standard medical care, while the control group will continue with standard care only. Primary and secondary outcomes will be assessed using validated self-report instruments, including the Perceived Stress Scale (PSS), Hospital Anxiety and Depression Scale (HADS), and COPE Inventory, administered at baseline and after the intervention period. The main objective of the study is to determine whether structured mind-body techniques can reduce perceived stress, anxiety, and depressive symptoms and improve coping strategies in patients with coronary artery disease.
Protocol Amendment History 1 change
critical Recruitment opened 2026-06-23
Trial Details
NCT Number NCT07633132
Lead Sponsor şeyda candeniz
Conditions Coronary Artery Disease (CAD)
Enrollment 40 participants
Start Date 2026-06-09
Primary Completion 2026-08 (estimated)
Study Completion 2026-09 (estimated)
Updated on ClinicalTrials.gov 2026-06-22